Animal Care and UseAward ManagementConflicts of InterestContracts and SubawardsControlled SubstancesEnvironmental Health and SafetyExport ControlHIPAAHuman Stem Cell ResearchHuman Subjects Research

NIH/AHRQ/NIOSH Grant Application COVID-19 Updates

Published May 16, 2022

In the release of NOT-OD-22-112, the National Institutes of Health (NIH) extends the guidance provided earlier (NOT-OD-22-046 and NIH-OD-21-180) for applicants preparing applications for the January 2023 Council round, beginning with the May 25, 2022 due date.

  • Reviewers will continue to receive instructions to assume that constraints arising from the COVID-19 pandemic (e.g., lab occupancy restrictions, declines in patient accrual, etc.) will be resolved during the project period and thus should not affect their scores.
  • Therefore, NIH grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic. However, applicants may address effects due to the pandemic on productivity or other scoreable issues in their Personal Statement in the NIH Biosketch. Reviewers will be instructed to take these pandemic-related circumstances into account when assessing applicants’ productivity and other score-driving factors.
  • As with previous instructions, if needed, NIH staff will request and assess plans to resolve specific problems arising from the COVID-19 pandemic prior to funding.

In the release of NOT-OD-22-113, NIH, AHRQ, and NIOSH extend the special exception for post-submission material to applications submitted for the August/October 2022 Council rounds.

  • For applications submitted for the January 2023 Council rounds (beginning with applications submitted for the May 25, 2022 due date), the NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, only if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.
  • The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting, unless specified otherwise in the FOA. Because applications for emergency competitive revisions and urgent competitive revisions undergo expedited review, post-submission materials will not be accepted for those applications.
  • All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting. Instructions for submission are included in NOT-OD-19-083.

If you have any questions, please contact the Office of Sponsored Research Services.